Wu Mingxing, Li Shaozhen, Zeng Junwen, Gao Jinsong, Liu Yizhi
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
Zhonghua Yan Ke Za Zhi. 2002 Jun;38(6):367-71.
To investigate the gene expression of cyclin E, cyclin-dependent-kinase 2 (CDK(2)) and CDK inhibitor (CKI) p21 during cell cycle of the human lens epithelial cell (HLEC) for elucidating the molecular mechanism of proliferation of HLEC and the formation of posterior capsular opacification (PCO).
HLE-B3 cell line was cultured in vitro under MEM medium with 15% fetal bovine serum. The cell cycle was analyzed by flow cytometry (FCM) system. The cell cycle was synchronized by double thymidine block method. The mRNA was detected by reverse transcription polymerase chain reaction (RT-PCR). The total RNA was separated from cells at different phases. Protein expression was detected with immunohistochemistry or western blotting method. The primary antibodies were rabbit anti-human cyclin E polyclonal antibody, mouse anti-human p21 and CDK(2) monoclonal antibody, respectively.
FCM showed that G(1) phase was about 33.5%, S phase cells about 46.1%, and the G(2) phase about 20.4%, total cells in G(2) and S phase were over 60%. It was suggested that HLE- B3 cells have relatively more capacity of mitosis than normal LEC. The mRNA expression of CDK(2) was found at all phases of cell cycle during synchronization, but cyclin E mRNA only expressed during synchronized cells, and not expressed in non-synchronized cells. Only Sphase cells could express very low p21 mRNA. There was no any positive signal of cyclin E by immunohistochemistry or western blot. CDK(2) protein detected by Western blot expressed at all phases. The p21 protein was expressed in a few cells by immunohistochemistry, but p21 could not detected by western blotting. These results showed cyclin E and CDK(2) were higher expressed than p21 in transcriptional level and translational level.
There is mRNA expression of cyclin E, CDK(2) and p21 during the cell cycle in HLE-B3 cell line, but it means the imbalance of the association of CDK and CKI. These results suggest that the imbalance expression of cyclin, CDK and p21 be the molecular mechanism of PCO.
研究细胞周期蛋白E、细胞周期蛋白依赖性激酶2(CDK2)及CDK抑制剂(CKI)p21在人晶状体上皮细胞(HLEC)细胞周期中的基因表达情况,以阐明HLEC增殖及后囊膜混浊(PCO)形成的分子机制。
HLE - B3细胞系在含15%胎牛血清的MEM培养基中体外培养。采用流式细胞术(FCM)系统分析细胞周期。通过双胸腺嘧啶核苷阻断法使细胞周期同步化。采用逆转录聚合酶链反应(RT - PCR)检测mRNA。从不同时期的细胞中分离总RNA。用免疫组织化学或蛋白质印迹法检测蛋白质表达。一抗分别为兔抗人细胞周期蛋白E多克隆抗体、小鼠抗人p21和CDK2单克隆抗体。
FCM显示,G1期约为33.5%,S期细胞约为46.1%,G2期约为20.4%,G2期和S期的细胞总数超过60%。提示HLE - B3细胞的有丝分裂能力比正常晶状体上皮细胞相对更强。在同步化过程中,细胞周期各阶段均检测到CDK2的mRNA表达,但细胞周期蛋白E的mRNA仅在同步化细胞中表达,非同步化细胞中不表达。仅S期细胞能表达极低水平的p21 mRNA。免疫组织化学或蛋白质印迹法均未检测到细胞周期蛋白E的阳性信号。蛋白质印迹法检测到的CDK2蛋白在各阶段均有表达。免疫组织化学显示p21蛋白在少数细胞中表达,但蛋白质印迹法未检测到p21。这些结果表明,在转录水平和翻译水平上,细胞周期蛋白E和CDK2的表达均高于p21。
HLE - B3细胞系在细胞周期中有细胞周期蛋白E、CDK2和p21的mRNA表达,但这意味着CDK与CKI之间的关联失衡。这些结果提示,细胞周期蛋白、CDK和p21的失衡表达是PCO的分子机制。